FUKUDA DENSHI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,800 JPY | +2.41% |
|
+1.80% | -7.73% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 132B 848M | Sales 2023 | 135B 865M | Capitalization | 129B 829M |
|---|---|---|---|---|---|
| Net income 2022 | 16.22B 104M | Net income 2023 | 17.28B 111M | EV / Sales 2022 | 0.43 x |
| Net cash position 2022 | 60.73B 390M | Net cash position 2023 | 64.79B 416M | EV / Sales 2023 | 0.48 x |
| P/E ratio 2022 |
7.28
x | P/E ratio 2023 |
7.47
x | Employees | 3,382 |
| Yield 2022 |
2.05% | Yield 2023 |
2.58% | Free-Float | 53.3% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.41% | ||
| 1 week | +1.80% | ||
| Current month | +3.82% | ||
| 1 month | +7.42% | ||
| 3 months | -15.63% | ||
| 6 months | +20.57% | ||
| Current year | -7.73% |
1 week
6 530.00
6 950.00
1 month
6 100.006 950.00
Current year
6 100.008 740.00
1 year
4 385.008 740.00
3 years
3 470.008 740.00
5 years
3 180.008 740.00
10 years
2 585.008 740.00
| Managers | Title | Age | Since |
|---|---|---|---|
Daijiro Shirai
PSD | President | 72 | 80-03-31 |
Kotaro Fukuda
CHM | Chairman | 78 | 68-03-31 |
Naoki Hisano
BRD | Director/Board Member | 55 | 98-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kazuki Furuya
BRD | Director/Board Member | 74 | 22-05-31 |
Kotaro Fukuda
CHM | Chairman | 78 | 68-03-31 |
Shuichi Fukuda
BRD | Director/Board Member | 69 | 78-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.60% | 0 M€ | +4.19% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 6,800 | +2.41% | 50 000 |
| 24-05-08 | 6,640 | +0.45% | 18,700 |
| 24-05-07 | 6,610 | -1.05% | 27,000 |
| 24-05-02 | 6,680 | +1.67% | 25,000 |
| 24-05-01 | 6,570 | +0.31% | 25,400 |
Delayed Quote Japan Exchange, May 09, 2024 at 02:00 am EDT
More quotes
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
Calendar
2024-05-14
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -7.73% | 1.23B | |
| +8.45% | 219B | |
| +7.90% | 185B | |
| +14.18% | 135B | |
| +27.51% | 107B | |
| +13.70% | 51.28B | |
| +4.88% | 51.01B | |
| +3.76% | 41.85B | |
| +6.28% | 37.02B | |
| +24.98% | 31.27B |
- Stock Market
- Equities
- 6960 Stock